Friday, October 06, 2006

PANC



LONG HERE

2 Comments:

Anonymous Anonymous said...

This think is going to 15-18 soon.
Will be bought out in my opinion

1:24 PM  
Anonymous Anonymous said...

I agree that Panacos is a likely acquisition candidate. The FDA is extremely interested in this little company and is rooting for them. Maturation inhibitors, a class of AIDS drug unique to Panacos, show up in all sorts of FDA presentations on the state of AIDS research. And the biotech sector as a whole has been beaten up long enough. Where else can one find such explosive growth potential?

10:16 PM  

Post a Comment

<< Home